| Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer M Isikbay, K Otto, S Kregel, J Kach, Y Cai, DJ Vander Griend, SD Conzen, ... Hormones and Cancer 5, 72-89, 2014 | 329 | 2014 |
| Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer S Kregel, JL Chen, W Tom, V Krishnan, J Kach, H Brechka, TB Fessenden, ... Oncotarget 7 (18), 26259, 2016 | 105 | 2016 |
| Perineural invasion and risk of lethal prostate cancer P Zareba, R Flavin, M Isikbay, JR Rider, TA Gerke, S Finn, A Pettersson, ... Cancer Epidemiology, Biomarkers & Prevention 26 (5), 719-726, 2017 | 76 | 2017 |
| Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant … EE Reyes, DJ VanderWeele, M Isikbay, R Duggan, A Campanile, ... Journal of translational medicine 12, 1-15, 2014 | 50 | 2014 |
| Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer EE Reyes, M Gillard, R Duggan, K Wroblewski, S Kregel, M Isikbay, ... Journal of translational science 1 (1), 2015 | 23 | 2015 |
| Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma AS Kibel, J Ahn, M Isikbay, A Klim, WS Wu, RB Hayes, WB Isaacs, ... The Prostate 76 (5), 479-490, 2016 | 15 | 2016 |
| The effects of cheliped autotomy and regeneration on aggression in purple shore crabs (Hemigrapsus nudus) TL Maginnis, M Isikbay, SG Degerstedt, TJ Luethke, M Ortman Marine and freshwater behaviour and physiology 48 (4), 241-251, 2015 | 10 | 2015 |
| Metabolism of megestrol acetate in vitro and the role of oxidative metabolites L House, MJ Seminerio, S Mirkov, J Ramirez, M Skor, JR Sachleben, ... Xenobiotica 48 (10), 973-983, 2018 | 8 | 2018 |
| Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014; 5 (2): 72–89 M Isikbay, K Otto, S Kregel, J Kach, Y Cai, DJ Vander Griend, SD Conzen, ... | 5 | |
| Family history of prostate cancer and the incidence of ERG‐and phosphatase and tensin homolog‐defined prostate cancer D Hashim, AG Gonzalez‐Feliciano, TU Ahearn, A Pettersson, L Barber, ... International journal of cancer 146 (10), 2694-2702, 2020 | 4 | 2020 |
| Tradeoffs associated with autotomy and regeneration and their potential role in the evolution of regenerative abilities T Prestholdt, T White-Toney, K Bates, K Termulo, S Reid, K Kennedy, ... Behavioral Ecology 33 (3), 518-525, 2022 | 2 | 2022 |
| Characterization of GLB1 cDNA from normal and GM1-gangliosidosis affected ovine fibroblasts to confirm a possible disease-causing mutation BR Dieter, DO Bailey, M Isikbay, AJ Ahern-Rindell Molecular Genetics and Metabolism 111 (3), 269-269, 2014 | 1 | 2014 |
| Evaluation of GLB1 In a Novel Ovine Model of GM1-Gangliosidosis A Ahern-Rindell, M Isikbay, B McInturff, M Supinski Molecular Genetics and Metabolism 2 (105), S15, 2012 | 1 | 2012 |
| Gene expression profiling of prostate tissue identifies biological pathways associated with TMPRSS2:ERG gene fusion E Ebot, M Isikbay, T Gerke, TU Ahearn, RS Kelly, S Tyekucheva, ... Cancer Research 77 (13_Supplement), 4236-4236, 2017 | | 2017 |
| Alterations in the binding of Meis proteins to HoxB13 or to DNA promote prostate cancer progression HJ Brechka, M Isikbay, R Bhanvadia, D Vander Griend Cancer Research 75 (15_Supplement), 2243-2243, 2015 | | 2015 |
| METABOLISM OF MEGESTROL ACETATE IN VITRO AND THE ROLE OF OXIDATIVE METABOLITES. MJ Seminerio, L House, S Mirkov, J Ramirez, J Sachleben, M Isikbay, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 95, S28-S28, 2014 | | 2014 |
| Androgen receptor independent acquired mechanisms of resistance to enzalutamide in castration-resistant prostate cancer. RZ Szmulewitz, S Kregel, M Isikbay, Y Cai, JL Chen, DJ Vander Griend Journal of Clinical Oncology 32 (4_suppl), 129-129, 2014 | | 2014 |
| Feasibility of multimodal molecular characterization of the androgen receptor (AR) in circulating tumor cells (CTCs) from patients with castrate-resistant prostate cancer (CRPC). DJ VanderWeele, M Isikbay, E Reyes, R Duggan, AJ Wyche, WM Stadler, ... Journal of Clinical Oncology 32 (4_suppl), 133-133, 2014 | | 2014 |
| A size comparison of beta-galactosidase isolated from fibroblasts from normal and GM1-affected sheep A Ahern-Rindell, M Isikbay Molecular Genetics and Metabolism 108 (2), S17, 2013 | | 2013 |
| Characterization Of The Lysosomal Protein Beta-Galactosidase In Gm1-Gangliosidosis Affected Sheep M Isikbay 2012 NCUR, 2012 | | 2012 |
